Background
The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear.Methods
We conducted a randomized, controlled, adaptive platform trial involving predominantly...
